Washington Trust’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-93
Closed -$1.18K 914
2023
Q3
$1.18K Sell
93
-5
-5% -$69 ﹤0.01% 830
2023
Q2
$1.39K Buy
98
+13
+15% +$183 ﹤0.01% 833
2023
Q1
$1.27K Buy
85
+14
+20% +$212 ﹤0.01% 864
2022
Q4
$1.05K Buy
71
+2
+3% +$33 ﹤0.01% 902
2022
Q3
$1K Sell
69
-8
-10% -$161 ﹤0.01% 882
2022
Q2
$2K Sell
77
-4
-5% -$82 ﹤0.01% 811
2022
Q1
$2K Sell
81
-4
-5% -$98 ﹤0.01% 836
2021
Q4
$2K Buy
85
+15
+21% +$402 ﹤0.01% 842
2021
Q3
$2K Hold
70
﹤0.01% 965
2021
Q2
$2K Buy
70
+1
+1% +$30 ﹤0.01% 950
2021
Q1
$2K Buy
69
+21
+44% +$538 ﹤0.01% 910
2020
Q4
$1K Buy
+48
New +$901 ﹤0.01% 944

Other funds holding MD

Washington Trust's MD Position: Q4 2023 in Review

Washington Trust sold out of Pediatrix Medical (MD) in Q4 2023, closing a stake of 93 shares — an estimated $1.18K sold.

Washington Trust first reported a position in MD in Q4 2020 and held it in 12 quarters. The position peaked at $2K in Q2 2022. 223 funds tracked by Wall St. Rank hold MD as of Q4 2023.

  • Washington Trust reported no remaining Pediatrix Medical position as of Q4 2023 after selling out during the quarter.
  • Washington Trust sold 93 Pediatrix Medical shares in Q4 2023, an estimated $1.18K.
  • Washington Trust first reported a position in Pediatrix Medical in Q4 2020 and held it in 12 quarters.
  • Washington Trust's Pediatrix Medical position peaked at $2K in Q2 2022.
  • 223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2023.

Based on Washington Trust's 13F filing for Q4 2023, filed 18 Jan 2024.